Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the recipient of a significant decline in short interest in August. As of August 14th, there was short interest totaling 11,741 shares, a decline of 38.8% from the July 30th total of 19,190 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average daily trading volume, of 22,301 shares, the short-interest ratio is presently 0.5 days.
Innovator IBD 50 ETF Stock Performance
NYSEARCA FFTY opened at $36.58 on Monday. Innovator IBD 50 ETF has a 1-year low of $31.61 and a 1-year high of $44.08. The company has a 50 day moving average of $38.76 and a 200-day moving average of $38.47. The firm has a market cap of $78.65 million, a price-to-earnings ratio of 30.34 and a beta of 1.47.
Hedge Funds Weigh In On Innovator IBD 50 ETF
Several institutional investors have recently bought and sold shares of FFTY. NewEdge Advisors LLC acquired a new position in Innovator IBD 50 ETF in the first quarter worth $306,000. Bank of America Corp DE grew its holdings in Innovator IBD 50 ETF by 307.2% during the 2nd quarter. Bank of America Corp DE now owns 12,448 shares of the company’s stock worth $404,000 after acquiring an additional 9,391 shares during the last quarter. JPMorgan Chase & Co. bought a new position in shares of Innovator IBD 50 ETF in the third quarter worth about $478,000. BNP Paribas Financial Markets acquired a new position in shares of Innovator IBD 50 ETF during the third quarter worth approximately $1,494,000. Finally, Prosperity Wealth Management Inc. bought a new stake in shares of Innovator IBD 50 ETF during the third quarter valued at approximately $637,000.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Further Reading
- Five stocks we like better than Innovator IBD 50 ETF
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
